DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Reply Not Fully Responsive
The reply filed on 10/13/2026 is not fully responsive to the prior Office action because of the following omission(s) or matter(s):
As filing a terminal disclaimer, or filing a showing that the claims subject to the rejection are patentably distinct from the reference application’s claims, is necessary for further consideration of the rejection of the claims, such a filing should not be held in abeyance. Only objections or requirements as to form not necessary for further consideration of the claims may be held in abeyance until allowable subject matter is indicated. Therefore, an application must not be allowed unless the required compliant terminal disclaimer(s) is/are filed and/or the withdrawal of the nonstatutory double patenting rejection(s) is made of record by the examiner. See MPEP § 804.02, subsection VI., for filing terminal disclaimers required to overcome nonstatutory double patenting rejections in applications filed on or after June 8, 1995. (emphasis added.)
Since the above-mentioned reply appears to be bona fide, Applicant’s response has been fully considered. However, future replies must be fully responsive. A deliberate omission will not be treated as a bona fide attempt.
Information Disclosure Statement
The information disclosure statement (IDS) submitted on 10/14/2026 has beenconsidered by the examiner.
Claim Rejections - 35 USC § 112
The following is a quotation of the first paragraph of 35 U.S.C. 112(a):
(a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention.
The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112:
The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention.
Claims 1-6 are rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention.
The newly added claim limitation “having a peak at about 1000 cm-1” in line 3 of claim 1 was not originally disclosed in the application as filed. Applicant relies on Figure 10 as support for the limitation. However, an examination of Figure 10 demonstrates that the spectrum fails to convey to a person of ordinary skill in the art that the applicant was in possession of a materially characterized by an absorption peak at 1000 cm-1 at the time of filing for the following reasons:
Absence of a Local Maximum / Peak Apex: The spectrum in Figure 10 exhibits a distinct, major absorption peak with an apex at approximately 1150 cm-1, along with a shoulder feature at approximately 1080 – 1085 cm-1.
Characterization at 1000 cm-1: The wavenumber position 1000 cm-1 corresponds merely to a sloping absorption envelope / local inflection, rather than a discrete, identifiable absorption peak (local maximum/transmittance minimum).
PNG
media_image1.png
485
381
media_image1.png
Greyscale
Mismatch with Spectrum: Identifying a “peak at about at 1000 cm-1” directly contradicts with the visual spectral data presented in Figure 10.
Because the specification and original drawings do not reasonably convey that the inventor possessed a composition or material defined specifically by an FTIR Peak at 1000 cm-1, the insertion of this limitation introduces new matter under 35 U.S.C. 112(a).
Claim Rejections - 35 USC § 102/103
In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status.
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action:
A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made.
The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows:
1. Determining the scope and contents of the prior art.
2. Ascertaining the differences between the prior art and the claims at issue.
3. Resolving the level of ordinary skill in the pertinent art.
4. Considering objective evidence present in the application indicating obviousness or nonobviousness.
Claims 1-3 are rejected under 35 U.S.C. 102(a)(1) as anticipated by or, in the alternative, under 35 U.S.C. 103 as obvious over Rusev, et al. (Bulg. Chem. Commun, 2018) as evidenced by Onija et al. (AIP Conference Proceedings, 2012).
In regard to claim 1, Rusev et al. disclose a hydrated complex comprising magnesium chloride and urea (e.g. bis(aqua) tetrakis(urea-O) magnesium dichloride, [U4Mg(H2O)2]2+.2Cl–) [pg. 80, col. 1, 3rd heading], which in a crystalline form (e.g. aqueous solution single crystal obtained) [pg. 80, col. 1, 4th full para.].
While Rusev does not explicitly disclose the Fourier transform infrared spectrum having a peak at about 1000 cm-1, where the claimed and prior art products are identical or substantially identical in structure or composition, or are produced by identical or substantially identical processes, a prima facie case of either anticipation or obviousness has been established. In re Best, 562 F.2d 1252, 1255, 195 USPQ 430, 433 (CCPA 1977). In this case the composition disclosed by Rusev is the same and thus must necessarily exhibit the properties. [MPEP 2112.01]. Alternatively, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention that the crystalline combination of urea and magnesium chloride disclosed by Rusev would exhibit the FTIR spectra of Applicant’s Nitromag (Nitro-Mag is a combination of MgCl2 and urea) [Specification para. 0041] which is a dried and crystallized product (e.g. Rusev discloses a drying via evaporation to obtain the crystalline product) [pg. 80, col. 1, 4th full para.]. Furthermore, the characteristic peaks of urea can be recognized in the pure urea spectrum as to be: ν(CO) 1673 cm–1 , ν(C=O) + δ(N-H) 1629 cm–1, ν(C-N) 1467 cm–1, γ NH2 1153 cm–1, δNH2 1055 cm–1, ν(C-N) 1000 cm–1 [Onija, pg. 36, Figure 2]. The urea component of Rusev’s hydrated complex would therefore be expected o exhibit the characteristic absorption band of ~1000 cm⁻¹ attributed to the ν(C–N) stretching vibration and ~1055 cm⁻¹ attributed to the δ(NH₂) rocking or bending vibration.
In regard to claims 2-3, as a practical matter, it is noted that the Patent Office is not equipped to manufacture products by the myriad of processes put before it and then obtain prior art products and make physical comparisons therewith, In re Brown, 459 F.2d 531, 535, 173 USPQ 685, 688 (CCPA 1972) — therefore, based on the preponderance of evidence with particular attention to Rusev’s teachings of the hydrated complex of magnesium chloride and urea [pg. 80, col. 1, 3rd heading] obtained by dissolving magnesium chloride and urea in water and drying to obtain a crystalline solid [pg. 80, col. 1, 4th full para.], there is a reasonable prima facie basis to presume that the chemical complex of Rusev would be the same as or obvious from the product produced by the claimed process, absent evidence to the contrary. Furthermore, the fertilizer nutrient ratio (e.g. N:P:K) of the chemical complex taught by Rusev ([U4Mg(H2O)2]2+.2Cl–) [pg. 80, col. 1, 3rd heading], is about 23:0:0 when calculated based on the weight of the crystalline hydrated complex. An aqueous liquid composition of MgCl2 and urea would necessarily exhibit a neutral pH between 7-8 and remain solubilized in the liquid composition at the claimed temperatures because the freezing point of the aqueous solution decreases due to the freezing point depression effect. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to optimize the amount of magnesium component present in Rusev’s chemical complex through routine experimentation. Here, where the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation. [MPEP 2114.05]. In this case, the concentration of magnesium chloride starting material for forming the hydrated complex may be chosen by one of ordinary skill in the art without undue experimentation.
Claims 4-6 are rejected under 35 U.S.C. 103 as being unpatentable over Rusev, et al. (Bulg. Chem. Commun, 2018) as applied to claim 2 above, and further in view of Dietrich et al. (US 20160046534 A1).
In regard to claims 4-6, Rusev does not explicitly disclose wherein the hydrated complex is formed using a solution of magnesium chloride further comprising boron (claim 4), wherein the fertilizer ratio is about 24 N : 0 P : 0 K : 4 Mg : 10 Cl : 0.35 B (claim 5) or wherein the liquid composition further comprises molybdenum (claim 6).
Dietrich et al. is directed to magnesium-urea complexes for fertilization [0001]. Dietrich describes salts of magnesium for use as fertilizers or fertilizer additives. “Usually these salts are used as magnesium sulfate in conjunction with macronutrients such as potassium, phosphorus or nitrogen as well as with trace elements such as manganese, zinc, copper, iron, cobalt, molybdenum or boron.” [0002]. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to formulate a multi-nutrient fertilizer composition comprising the trace element nutrients such as molybdenum or boron within the claimed ranges. One of ordinary skill in the art would have been motivated to do so to achieve a complete nutritive composition thereby providing effective amounts of necessary trace nutrients as a fertilizer or fertilizer additive.
Double Patenting
The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969).
A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b).
The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13.
The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer.
Claims 1-6 are provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-3, 5, 14, 19, 20-21 and 28-29 of copending Application No. 18/733,212 (reference application). Although the claims at issue are not identical, they are not patentably distinct from each other because the claims being examined are generic to a species or sub-genus claimed in a conflicting application (i.e., the entire scope of the reference claim falls within the scope of the examined claim). The species or sub-genus claimed in the conflicting application anticipates the claimed genus in the application being examined and, therefore, a patent to the genus would improperly extend the right to exclude granted by a patent to the species or sub-genus should the genus issue as a patent after the species or sub-genus.
This is a provisional nonstatutory double patenting rejection because the patentably indistinct claims have not in fact been patented.
Response to Arguments
Applicant argues (pg. 2, last 2 paragraphs) the crystal composition disclosed by the Rusev prior art is prepared at room temperature in contrast to the claimed composition which is prepared at a temperature of at least 45 °C. Applicants point to Figures 10-12 which show N-Mag compared to ambient mixtures or heated mixtures of magnesium chloride and urea. However, these comparisons are directed to magnesium chloride and urea in solution which is not applicable to the materials described by the Rusev reference which in which liquid is evaporated and crystal samples are obtained [pg. 80, col. 1, 4th full para.].
The declaration under 37 CFR 1.132 filed 10/13/2026 is insufficient to overcome the rejection of the claims based upon the teachings of the Rusev prior art as set forth in the last Office action because the evidence does not establish results which are unexpected and significant. Evidence of unexpected properties may be in the form of a direct or indirect comparison of the claimed invention with the closest prior art which is commensurate in scope with the claims. See In re Boesch, 617 F.2d 272, 205 USPQ 215 (CCPA 1980). Here, declarant compares their Nitro-Mag with a 1:1 mixture of MgCl2 and urea whereas the closest prior art is a 1:4 molar ratio of anhydrous magnesium chloride and urea dissolved in water followed by slow evaporation. Applicants results are not considered a comparison of the claimed invention with the closest prior art. Thus, there is no showing that the objective evidence of nonobviousness is commensurate in scope with the claims. See MPEP § 716.
For these reasons, Applicant's arguments filed 10/13/2026 have been fully considered but they are not persuasive.
Conclusion
Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a).
A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to Jennifer A Smith whose telephone number is (571)270-3599. The examiner can normally be reached Monday - Friday 9:30am-6pm EST.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Amber R Orlando can be reached at (571) 270-3149. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/JENNIFER A SMITH/Primary Patent Examiner, Art Unit 1731 October 20, 2026